Serum Lipopolysaccharide Is Associated with the Recurrence of Atrial Fibrillation after Radiofrequency Ablation by Increasing Systemic Inflammation and Atrial Fibrosis
Table 1
Characteristics of subjects with AF study According to RAF.
Variables
All
SR maintenance
AF recurrence
()
()
()
Age (year)
0.265
Male, (%)
98 (61.6%)
72 (62.6%)
26 (59.1%)
0.638
Persistent AF, (%)
64 (40.3%)
42 (36.8%)
22 (50.0%)
0.121
Hypertension, (%)
85 (53.5%)
56 (49.1%)
29 (65.9%)
0.052
Diabetes, (%)
21 (13.2%)
13 (11.3%)
8 (18.2%)
0.252
CHD, (%)
35 (22.0%)
24 (20.9%)
11 (25.0%)
0.574
Heart failure, (%)
34 (21.4%)
13 (11.3%)
21 (47.7%)
< 0.001
BMI (kg/m2)
0.082
Glu (mmol/L)
5.04 (4.64-5.79)
4.99 (4.64-5.79)
5.20 (4.59-5.82)
0.599
LDL (mmol/L)
0.432
HDL (mmol/L)
1.07 (0.93-1.36)
1.08 (0.94-1.36)
1.06 (0.85-1.36)
0.437
TC (mmol/L)
0.916
TG (mmol/L)
1.44 (0.99,2.25)
1.38 (1.01-1.36)
1.33 (0.98-2.05)
0.605
Cr (μmol/L)
71 (58-81)
69 (57-80)
72 (60-86)
0.127
LAD (mm)
< 0.001
Hs-CRP (mg/L)
0.55 (0.41-0.72)
0.52 (0.40-0.68)
0.57 (0.47-0.79)
0.064
LPS (pg/mL)
0.001
IL-6 (pg/mL)
0.004
CITP (ng/mL)
0.004
TGF-β1 (ng/mL)
0.030
CHD: coronary heart disease; BMI: body mass index; LAD: left atrial diameter; IL-6: interleukin-6; CITP: collagen type-1 C-terminal telopeptide; TGF-β1: transforming growth factor beta1; LPS: lipopolysaccharide.
